BRIEF published on 10/16/2025 at 10:15, 3 months 29 days ago C-Path Launches Global Pediatric IBD Project from European Hub Drug Development Global Initiative Pediatric IBD Disease Modeling Regulatory Science
BRIEF published on 10/16/2025 at 10:15, 3 months 29 days ago C-Path lance un projet mondial sur les MII pédiatriques depuis son hub européen Développement De Médicaments MICI Pédiatrique Modélisation Des Maladies Science Réglementaire Initiative Mondiale
PRESS RELEASE published on 10/16/2025 at 10:10, 3 months 29 days ago C-Path's Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute launches Disease Modeling Coalition to accelerate pediatric IBD drug development with experts from ESPGHAN and support from Crohn's & Colitis Foundation Drug Development Pediatric IBD Critical Path Institute Disease Modeling Coalition Crohn's & Colitis Foundation
Published on 02/14/2026 at 01:00, 10 hours 9 minutes ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 12 hours 54 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 17 hours 24 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 20 hours 34 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 06:05, 5 hours 4 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 15 hours 49 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 16 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 16 hours 49 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 17 hours 1 minute ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 18:05, 17 hours 4 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 17 hours 4 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 17 hours 19 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 17 hours 19 minutes ago Nombre total d'actions et droits de vote - janvier 2026
